A new therapeutic strategy for hepatocellular cancer (HCC) that initially primes the tumor with an immune checkpoint inhibitor before using a multikinase inhibitor drug showed great promise for treating patients with the ...
Mar 16, 2022
0
45
It's surprisingly hard to tell when a brain cell is dead. Neurons that appear inactive and fragmented under the microscope can persist in a kind of life-or-death limbo for days, and some suddenly begin signaling again after ...
Dec 8, 2021
0
112
A new understanding of the causes of small cell lung cancer (SCLC) could lead to more personalized treatments and lower mortality from this deadly disease.
Nov 29, 2021
0
0
Each year, about half a million children in Africa die from malaria. Infection with the malaria parasite is such a widespread and deadly disease that scientists all over the globe are working to understand it better in order ...
Nov 12, 2021
0
137
A University of California, Irvine-led study suggests that the glucosyltransferase domain (GTD) is an ideal molecular target for therapeutic interventions for Clostridioides difficile infection (CDI). These findings may lead ...
Oct 22, 2021
0
66
Tuberculosis (TB) is still one of the biggest infectious killers in the world. Multiple drug resistant (MDR) TB has become a global health emergency, an emerging European crisis, and an important Irish public health concern. ...
Oct 7, 2021
0
27
A new publication by Yale Cancer Center highlights recent breakthrough therapies developed to treat non-small cell lung cancer (NSCLC). The goal of the study is to provide views on how basic science advances will impact clinical ...
Aug 12, 2021
0
331
Some survivors of ebolavirus outbreaks make antibodies that can broadly neutralize these viruses—and now, scientists at Scripps Research have illuminated how these antibodies can disable the viruses so effectively. The ...
Apr 15, 2021
0
15
Groundbreaking research from Tel Aviv University may lead to a significant breakthrough in the battle against deadly brain cancer. To begin with, the researchers identified a failure in the brain's immune system, leading ...
Apr 12, 2021
0
72
An early clinical trial in individuals with the deadly brain cancer, glioblastoma, showed an experimental spherical nucleic acid (SNA) drug developed by Northwestern University scientists was able to penetrate the blood-brain ...
Mar 10, 2021
0
1478
